Cargando…
Efficacy of (S)-lacosamide in preclinical models of cephalic pain
Migraine is one of the world's most common neurological disorders. Current acute migraine treatments have suboptimal efficacy, and new therapeutic options are needed. Approaches targeting calcitonin gene related peptide (CGRP) signaling are clinically effective, but small molecule antagonists h...
Autores principales: | Moutal, Aubin, Eyde, Nathan, Telemi, Edwin, Park, Ki Duk, Xie, Jennifer Y., Dodick, David W., Porreca, Frank, Khanna, Rajesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127447/ https://www.ncbi.nlm.nih.gov/pubmed/27917413 http://dx.doi.org/10.1097/PR9.0000000000000565 |
Ejemplares similares
-
The functionalized amino acid (S)-Lacosamide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth
por: Wilson, Sarah M., et al.
Publicado: (2014) -
Efficacy and Safety of Lacosamide in Painful Diabetic Neuropathy
por: Ziegler, Dan, et al.
Publicado: (2010) -
Chimeric Agents Derived from the Functionalized Amino
Acid, Lacosamide, and the α-Aminoamide, Safinamide: Evaluation
of Their Inhibitory Actions on Voltage-Gated Sodium Channels, and
Antiseizure and Antinociception Activities and Comparison with Lacosamide
and Safinamide
por: Park, Ki Duk, et al.
Publicado: (2014) -
Evaluation of edonerpic maleate as a CRMP2 inhibitor for pain relief
por: Moutal, Aubin, et al.
Publicado: (2019) -
CRMP2 is necessary for Neurofibromatosis type 1 related pain
por: Moutal, Aubin, et al.
Publicado: (2017)